Used in research settings as a potent and selective antagonist for serotonin 5-HT2A receptors. It serves as a pharmacological tool to study the role of 5-HT2A receptor activity in neurological pathways, particularly in models related to psychosis, mood disorders, and hallucinogen action. Its high affinity and unique structural properties make it valuable in receptor binding assays and in vivo studies exploring central nervous system function. Due to its bromine and trifluoromethyl groups, it is also employed in radiolabeling experiments for positron emission tomography (PET) imaging probe development. Not intended for therapeutic use.